Shire announces divestiture of Daytrana to Noven Pharmaceuticals

Links shared publicly online about this topic.

  • 955
    total visits

Shire announces divestiture of Daytrana to Noven Pharmaceuticals

news-medical.net

Shire plc, the global specialty biopharmaceutical company, announced the divestiture of Daytrana (methylphenidate transdermal system) to Noven Pharmaceuticals, Inc. Daytrana, which is approved and marketed in the US for the treatment of Attention Deficit Hyperactivity Disorder in children and adolescents, will continue to be available for patients through Noven.

View full resource at news-medical.net

Tags: Stroke, ADHD Medication, Thrombotic Event, Pharma, Concerta, Metadate CD, Shire, News

  • Share

Most Recently Shared on August 11, 2010 at 4:46 pm By:

Stroke_News News-Medical.Net

Stroke News: Shire announces divestiture of Daytrana to Noven Pharmaceuticals: Shire plc, the global specialty b... http://twurl.nl/20p7k8

2 years ago...

Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire - Drugs.com MedNews

drugs.com — “First and Only Patch for ADHD Now to be Marketed and Sold by Noven Therapeutics Oct 1, 2010 - Noven Pharmaceuticals, Inc. today announced that it has completedView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 1, 2010 at 4:19 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Noven Completes Acquisition of Daytrana Methylphenidate Transdermal System (CII) from Shire: First and Only P... http://bit.ly/9YGHxH #drug

2 years ago...

Noven acquires global rights to Daytrana from Shire affiliates

news-medical.net — “Noven Pharmaceuticals, Inc. today announced that it has completed the acquisition of global rights to Daytrana® (methylphenidate transdermal system) from affiliates of Shire plc.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on October 1, 2010 at 2:20 pm By:

NewsMedical News-Medical.Net Health News

Noven acquires global rights to Daytrana from Shire affiliates: Noven Pharmaceuticals, Inc. today announced that i... http://bit.ly/dpepvb

2 years ago...

Shire To Divest Brain Stimulator Daytrana To Noven Pharma; Maintains FY10 Earnings View

rttnews.com — “Specialty biopharmaceutical company Shire plc, Tuesday announced the divestiture of its brain stimulant medicine Daytrana to Noven Pharmaceuticals, Inc., granting Noven global marketing rights for the medicine, effective October 1, 2010.View full resource at rttnews.com

  • View Related
  • Share

Most Recently Shared on August 11, 2010 at 3:09 am By:

PeterBrownPsy Peter H Brown Psychologist and Doctor

Shire To Divest Brain Stimulator Daytrana To Noven Pharma; Maintains FY10 ... http://bit.ly/ahRdPa #ADHD

2 years ago...

Advertisement